Skip to Main Content

Author Details

Daniel I S Rosenbloom
Merck & Co. Inc.
2011
35
19
PMIDPaper TitleJournal TitlePublished Year
36812345Potent targeted activator of cell kill molecules eliminate cells expressing HIV-1.Sci Transl Med2023
37660711Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial.Lancet Infect Dis2023
36790337Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study.Hepatol Commun2023
35207719Preliminary Acceptability of a Home-Based Peripheral Blood Collection Device for Viral Load Testing in the Context of Analytical Treatment Interruptions in HIV Cure Trials: Results from a Nationwide Survey in the United States.J Pers Med2022
35348047"We are looking at the future right now": community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States.HIV Res Clin Pract2022
36278321Prediction of frozen virus stability based on degradation mechanisms, real-time data and modeling.Bioanalysis2022
35968737Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptionsHIV Res Clin Pract2022
32147687Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir Size.J Infect Dis2021
32649866Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study.Lancet HIV2020
30978183Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size.PLoS Comput Biol2019
29447150Life cycle synchronization is a viral drug resistance mechanism.PLoS Comput Biol2018
30129208Insight into treatment of HIV infection from viral dynamics models.Immunol Rev2018
30262818Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.Nat Genet2018
27923679Evolutionary scalpels for dissecting tumor ecosystems.Biochim Biophys Acta Rev Cancer2017
28263318Spatiotemporal genomic architecture informs precision oncology in glioblastoma.Nat Genet2017
28341641Proliferation of latently infected CD4<sup>+</sup> T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics.J Exp Med2017
29168805Re-evaluating evolution in the HIV reservoir.Nature2017
28683094Correction: Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV.PLoS Pathog2017
26714716Measuring the Frequency of Latent HIV-1 in Resting CD4⁺ T Cells Using a Limiting Dilution Coculture Assay.Methods Mol Biol2016
27270107Clonal evolution of glioblastoma under therapy.Nat Genet2016
27560936Insufficient Evidence for Rare Activation of Latent HIV in the Absence of Reservoir-Reducing Interventions.PLoS Pathog2016
27119536Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV.PLoS Pathog2016
27345159Topological Data Analysis Generates High-Resolution, Genome-wide Maps of Human Recombination.Cell Syst2016
25822022Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.J Clin Invest2015
26478893Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1.Open Forum Infect Dis2015
26038564Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance.Proc Natl Acad Sci U S A2015
25693029Viremic relapse after HIV-1 remission in a perinatally infected child.N Engl J Med2015
24739203Frequency-dependent selection can lead to evolution of high mutation rates.Am Nat2014
25042999Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys.Nature2014
25097264Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1.Proc Natl Acad Sci U S A2014
24243014Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.Cell2013
22552382Evolutionary dynamics of HIV at multiple spatial and temporal scales.J Mol Med (Berl)2012
22941277Antiretroviral dynamics determines HIV evolution and predicts therapy outcome.Nat Med2012
22941151Mutation rate evolution in replicator dynamics.Bull Math Biol2012
20667876Imitation dynamics of vaccination behaviour on social networks.Proc Biol Sci2011
  • 1 - 35 of 35

Recommended Authors

Hanwei Sudderuddin
University of British Columbia
Career Start Year 2019
Number of shared co-authors 0
Shuntai Zhou
University of North Carolina at Chapel Hill
Career Start Year 2010
Number of shared co-authors 1
Samuel V Scarpino
Department of Health Sciences Northeastern University
Career Start Year 2009
Number of shared co-authors 0
Tian-Hao Zhang
David Geffen School of Medicine, University of California los angeles
Career Start Year 2009
Number of shared co-authors 0
Allison DeLong
School of Public Health, Brown University
Career Start Year 2007
Number of shared co-authors 0
Joel O Wertheim
University of California
Career Start Year 2007
Number of shared co-authors 2
Roger D Kouyos
Institute of Medical Virology, University of Zurich
Career Start Year 2006
Number of shared co-authors 2
Fabio Zanini
Stanford University
Career Start Year 2006
Number of shared co-authors 0
Pavitra Roychoudhury
Fred Hutchinson Cancer Center
Career Start Year 2004
Number of shared co-authors 4
Davey M Smith
University of California San Diego
Career Start Year 2001
Number of shared co-authors 8
Satish K Pillai
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 7
Edward P Browne
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 0
Sudhir Penugonda
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 1
Leor S Weinberger
Gladstone/UCSF Center for Cell Circuitry, Gladstone Institutes
Career Start Year 1999
Number of shared co-authors 3
Pardis C Sabeti
Harvard University
Career Start Year 1997
Number of shared co-authors 2
Viviana Simon
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 1
Marc A Suchard
University of California los angeles
Career Start Year 1997
Number of shared co-authors 3
Hulin Wu
School of Public Health, The University of Texas Health Science Center at Houston
Career Start Year 1997
Number of shared co-authors 2
Oliver Laeyendecker
Department of Medicine Johns Hopkins Medicine. Baltimore MD 21205USA.
Career Start Year 1996
Number of shared co-authors 5
Adam S Lauring
University of Michigan ann arbor
Career Start Year 1995
Number of shared co-authors 2
Wei Shao
Inc., Frederick National Laboratory for Cancer Research
Career Start Year 1993
Number of shared co-authors 2
Sharon R Lewin
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 11
Roger Paredes
Hospital Germans Trias i Pujol
Career Start Year 1992
Number of shared co-authors 4
Rafael Delgado
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year 1988
Number of shared co-authors 0
Ian Frank
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 8
Michael S Saag
University of Alabama at Birmingham
Career Start Year 1980
Number of shared co-authors 8
Bonaventura Clotet
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year 1979
Number of shared co-authors 5
Steven M Wolinsky
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 6
Amalio Telenti
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 3
Ronald Swanstrom
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 1972
Number of shared co-authors 4

Collaborators

Robert F Siliciano
Johns Hopkins University School of Medicine
Co-authored papers 13
Raul Rabadan
Columbia University Vagelos College of Physicians and Surgeons
Co-authored papers 5
Daria J Hazuda
Merck & Co. Inc.
Co-authored papers 4
Zhaoqi Liu
University of Chinese Academy of Sciences
Co-authored papers 3
Pablo Tebas
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 3
Luis J Montaner
Wistar Institute
Co-authored papers 3
In-Hee Lee
Children's Hospital Boston
Co-authored papers 3
Karam Mounzer
Co-authored papers 3
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 3
Yong Jae Shin
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers 3
Jiguang Wang
The Hong Kong University of Science and Technology
Co-authored papers 3
Timothy J Henrich
University of California san francisco
Co-authored papers 3
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 3
Jin-Ku Lee
Seoul National University, College of Medicine
Co-authored papers 3
Oliver Elliott
Columbia University
Co-authored papers 3
Pablo G Camara
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 3
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers 3
In-Hee Lee
Co-authored papers 3
Erik Ladewig
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Hyun Ju Kang
Genomic Medicine Institute, Medical Research Center, Seoul National University
Co-authored papers 2
Peter Bacchetti
University of California San Francisco
Co-authored papers 2
Sheila M Keating
University of California San Francisco
Co-authored papers 2
Ho Jun Seol
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Douglas D Richman
Center for AIDS Research, University of California San Diego
Co-authored papers 2
Timothy Chu
University of California Riverside
Co-authored papers 2
Daniel R Kuritzkes
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 2
Yun Jee Seo
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers 2
Jung-Il Lee
Gangnam Severance Hospital
Co-authored papers 2
Seung Won Choi
Samsung Medical Center, Sungkyunkwan University
Co-authored papers 2
Michael P Busch
Vitalant Research Institute
Co-authored papers 2
Release 1.2